跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alburx - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Alburx
Approved
STANDARD
Alburx
CSL Behring LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
92742f3b92aafd39
Company
CSL Behring LLC
Type
Standard
Approval Details
Approval Id
92742f3b92aafd39
Drug Approval Philippines Name
Alburx
Product Name
Alburx
Registration Number
BR-1277
Brand Name
Alburx
Generic Name
Human Albumin
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
200 g/L (20% w/v)
Manufacturer
CSL Behring LLC
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/csl-behring-llc
Issuance Date
03 January 2023
Expiry Date
07 June 2028
Pharmacologic Category
Plasma fractions for specific uses
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
92742f3b92aafd39
Type
Standard
Back to Philippines FDA Approvals